Literature DB >> 33599810

[Hearing rehabilitation with the Vibrant Soundbridge in patients with congenital middle ear malformation].

J M Hempel1, A Epp2, V Volgger3.   

Abstract

BACKGROUND: Congenital aural atresia, which is usually unilateral, causes hearing loss and aesthetic impairment. Besides tympanoplasty with/without canalplasty and bone conduction devices, active middle ear implants are also available for functional rehabilitation.
OBJECTIVE: This article aims to present a contemporary review on the treatment possibilities for middle ear malformations, with a focus on audiological rehabilitation with the Vibrant Soundbridge.
MATERIALS AND METHODS: A selective literature search for treatment possibilities was performed in PubMed up to October 2020, and personal clinical experiences are reported.
RESULTS: The Vibrant Soundbridge, which is approved for children ≥ 5 years, is suitable for treatment of middle ear malformations with a Jahrsdoerfer score ≥ 5. Although implantation of a Vibrant Soundbridge is surgically more demanding than implantation of a bone conduction device, the method is safe, delivers good auditory results (superior to bone conduction devices in terms of speech understanding and spatial hearing), does not involve intensive postsurgical care, and rarely requires revision surgery. The Vibrant Soundbridge can be coupled to (remnants of) the ossicular chain or the round window.
CONCLUSION: The Vibrant Soundbridge is an appropriate treatment method in patients with middle ear malformations who have suitable anatomical preconditions.

Entities:  

Keywords:  Audiologic rehabilitation; Conductive hearing loss; Congenital aural atresia; Hearing aid; Prostheses and implants

Year:  2021        PMID: 33599810     DOI: 10.1007/s00106-021-01004-5

Source DB:  PubMed          Journal:  HNO        ISSN: 0017-6192            Impact factor:   1.284


  54 in total

1.  Facial canal anatomy in patients with microtia: evaluation of the temporal bones with thin-section CT.

Authors:  Hideki Takegoshi; Kimitaka Kaga; Shigeru Kikuchi; Ken Ito
Journal:  Radiology       Date:  2002-12       Impact factor: 11.105

Review 2.  Surgical management of conductive hearing loss in children.

Authors:  Yael Raz; Lawrence Lustig
Journal:  Otolaryngol Clin North Am       Date:  2002-08       Impact factor: 3.346

3.  Prenatal exposure to mycophenolate mofetil: an updated estimate.

Authors:  Chagit Klieger-Grossmann; David Chitayat; Sharon Lavign; Kelly Kao; Facundo Garcia-Bournissen; Dee Quinn; Vicky Luo; Mathew Sermer; Sara Riordan; Carl Laskin; Ilan Matok; Rafael Gorodischer; Christina Chambers; Amalia Levi; Gideon Koren
Journal:  J Obstet Gynaecol Can       Date:  2010-08

4.  Hearing levels in patients with microtia: correlation with temporal bone malformation.

Authors:  Shin-ichi Ishimoto; Ken Ito; Shotaro Karino; Hideki Takegoshi; Kimitaka Kaga; Tatsuya Yamasoba
Journal:  Laryngoscope       Date:  2007-03       Impact factor: 3.325

5.  Association of microtia with maternal obesity and periconceptional folic acid use.

Authors:  Chen Ma; Suzan L Carmichael; Angela E Scheuerle; Mark A Canfield; Gary M Shaw
Journal:  Am J Med Genet A       Date:  2010-11       Impact factor: 2.802

6.  Microtia grade as an indicator of middle ear development in aural atresia.

Authors:  S E Kountakis; E Helidonis; R A Jahrsdoerfer
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1995-08

7.  The risk of cholesteatoma in congenital aural stenosis.

Authors:  R R Cole; R A Jahrsdoerfer
Journal:  Laryngoscope       Date:  1990-06       Impact factor: 3.325

8.  Surgical management of congenital conductive deafness.

Authors:  J B Farrior
Journal:  South Med J       Date:  1987-04       Impact factor: 0.954

9.  Microtia in Finland: comparison of characteristics in different populations.

Authors:  Samuli Suutarla; Jorma Rautio; Annukka Ritvanen; Sirpa Ala-Mello; Jussi Jero; Tuomas Klockars
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2007-06-04       Impact factor: 1.675

Review 10.  Maternal smoking in pregnancy and birth defects: a systematic review based on 173 687 malformed cases and 11.7 million controls.

Authors:  Allan Hackshaw; Charles Rodeck; Sadie Boniface
Journal:  Hum Reprod Update       Date:  2011-07-11       Impact factor: 15.610

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.